Growth trajectory Earth Science Tech shows revenue growth with a FY2026 revenue of $35.7M and net income of $3.6M, indicating improving profitability and scalability. This suggests a viable target for partnerships and scaled distribution deals with nutraceuticals, cosmeceuticals, and telehealth-related offerings.

Strategic acquisitions Recent acquisitions including Avenvi LLC and investments in DOConsultations and Villas Health indicate a strategic push into real estate, telehealth, and care delivery. This opens cross-sell opportunities with healthcare facilities, clinics, and wellness retailers seeking integrated health and wellness ecosystems.

Telehealth synergies With active investments in telehealth subsidiaries, there is potential to bundle nutraceuticals and phytoceuticals with telehealth services or remote care programs, appealing to consumer segments prioritizing accessible, science-based health solutions.

Global wellness focus The company targets health, wellness, nutrition, supplements, cosmetics, and alternative medicine, aligning with growing consumer demand for natural, science-backed products. This creates opportunities to partner with distributors and retailers seeking diversified, credible wellness portfolios.

Cap table and funding Funding of $2.3M against a revenue base under $1M signals room for capital-backed product launches and pilot programs. Sales teams can pursue strategic partnerships, co-marketing arrangements, and early adoption programs to accelerate market penetration.